CVRX Stock Analysis: Buy, Sell, or Hold?
CVRX - CVRx, Inc. Common Stock
$9.01
-0.09 (-0.99%)
▼
5d:
-2.91%
30d:
+6.12%
90d:
+26.9%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Distribution
CVRX is up 47.7% this week, but smart money is buying puts. Top strike: $5 2026-04-17 with 11 OI. Put ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When CVRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CVRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CVRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CVRX is currently trading at $9.01, which is considered extended relative to its 30-day fair value range of $7.64 to $8.94.
Technical Outlook: Technically, CVRX is in a downtrend. Immediate support is located at $8.13, while resistance sits at $9.84.
Market Sentiment: CVRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.17 (+23.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CVRX is in a downtrend. Immediate support is located at $8.13, while resistance sits at $9.84.
Market Sentiment: CVRX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.17 (+23.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$7.64 -
$8.94
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.9% below Wall St target ($11.17)
Fair Price Analysis
30-Day Fair Range
$7.64 -
$8.94
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$1.07
(11.9%)
Support & Resistance Levels
Support Level
$8.14
Resistance Level
$9.84
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.07
Wall Street Target
$11.17
(+23.9%)
Revenue Growth (YoY)
4.4%
Profit Margin
-94.1%
Share & Embed Analysis
Last updated: April 03, 2026 12:33 AM ET
Data refreshes hourly during market hours. Next update: 1:33 AM
Data refreshes hourly during market hours. Next update: 1:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVRX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Philip B Adamson
SELL
1262 shares
2026-03-02
Mudit K Jain
BUY
46800 shares
2026-02-20
Mudit K Jain
BUY
600 shares
2026-02-18
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
Advanced CVRX Option Strategies
Professional options setups generated by AI based on today's CVRX price and gamma walls.
